Back to top
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Image: Bigstock
Alder Biopharmaceuticals (ALDR) Jumps: Stock Rises 9.6%
Alder Biopharmaceuticals Inc. was a big mover last session, as its shares rose almost 10% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $28.72 to $32.10 in the past one-month time frame.
Over the last 30 days, the company witnessed one positive and two negative estimate revisions while the Zacks Consensus Estimate moved lower over the same time frame, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent move higher can last.
Alder Biopharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.
ALDER BIOPHARMA Price
ALDER BIOPHARMA Price | ALDER BIOPHARMA Quote
A better-ranked stock in the med-biomed/gene space is Geron Corporation (GERN - Free Report) , which sports a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>